Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Optima HealthFRA:J3N 22 EV-to-EBIT is 92.52 as of Sep. 03, 2026, which is 175% above its 10-year median of 33.69. GuruFocus rates FRA:J3N with a GF Score™ of 22/100. The stock has 9 warning signs investors should review. Among 476 Healthcare Providers & Services companies, Optima Health ranks worse than 93.28% on this metric.
The historical rank and industry rank for Optima Health's EV-to-EBIT or its related term are showing as below:
FRA:J3N'
s EV-to-EBIT Range Over the Past 10 Years
Min: -290.57 Med: 33.69 Max: 91.56
Current: 91.36
During the past 5 years, the highest EV-to-EBIT of Optima Health was 91.56. The lowest was -290.57. And the median was 33.69.
FRA:J3N's EV-to-EBIT is ranked worse than 93.28% of 476
companies
in the Healthcare Providers & Services industry
Industry Median: 15.505
vs FRA:J3N: 91.36
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Optima Health's Enterprise Value for the quarter that ended in Mar. 2026 was €295.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Optima Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was €4.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Optima Health EV-to-EBIT Related Terms
Optima Health EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Optima Health's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Optima Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Optima Health EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Optima Health's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Optima Health's EV-to-EBIT falls into.
Optima Health's current Enterprise Value is €429.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Optima Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was €4.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Optima Health (FRA:J3N) has a EV-to-EBIT of 92.52 as of Sep. 03, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Optima Health and its competitors. This is 175% above median its historical median of 33.69. According to the industry distribution chart, Optima Health ranks #444 out of 476 companies in the Healthcare Providers & Services industry, placing it in the top 93.3%.
Is Optima Health's EV-to-EBIT too high?
Optima Health's current EV-to-EBIT of 92.52 is 175% above median its 10-year median of 33.69. The Healthcare Providers & Services industry median EV-to-EBIT is 15.51. Optima Health's value of 92.52 is 496.7% above this industry median. Based on the distribution chart, Optima Health ranks #444 out of 476 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Optima Health has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Optima Health's EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Optima Health ranks #444 out of 476 companies for EV-to-EBIT. This places Optima Health in the lower half of its industry. The industry median EV-to-EBIT is 15.51. Optima Health's value of 92.52 is 496.7% above this benchmark. While the company's 10-year median is 33.69 vs. the industry median of 15.51, Optima Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.51, based on 476 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Optima Health's current EV-to-EBIT of 92.52 is 496.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Optima Health and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Optima Health's current EV-to-EBIT is 92.52, which is 175% above median its own 10-year median of 33.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optima Health stock overvalued right now?
Optima Health (FRA:J3N) has a current EV-to-EBIT of 92.52. The current EV-to-EBIT is 92.52, which is 175% above median its 10-year median of 33.69 and 496.7% above the Healthcare Providers & Services industry median of 15.51. Optima Health's overall GF Score™ is 22/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Optima Health (FRA:J3N), the current EV-to-EBIT is 92.52 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Optima Health PLC is a provider of technology-enabled corporate health and wellbeing solutions in the occupational health sector. The group offers a comprehensive range of flexible and progressive services, from statutory-driven workplace health surveillance medicals to proactive and preventive interventions, as well as workplace health advice and attendance management assessments. These services are ultimately rehabilitation programs and pathways designed to help people return to work.
22GF Score
Get the complete analysis for FRA:J3N
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:J3N has been successfully added to your 
